The practice of pathology is a critical element in any healthcare system. In fact, 70% of all healthcare decisions related to diagnosis and treatment are estimated to require pathology.1 Unfortunately, pathology[...]
As challenges in the practice of pathology continue to increase, leading healthcare companies are striving to provide relief. FUJIFILM Healthcare Americas Corporation has nearly a century of experience in medical[...]
Earlier this year, FUJIFILM Healthcare Americas Corporation expanded its portfolio with the introduction of Synapse® Pathology, its robust digital pathology PACS solution. Pathology is the last analog medical science to[...]
Last month we shared insights from Bill Lacy, senior vice president of Medical Informatics on why Fujifilm made its strategic business decision to enter the digital pathology market. We recently[...]
On January 23, 2023, Fujifilm completed its asset purchase of the Dynamyx business and welcomed the digital pathology business, technology, customers and employees to the Fujifilm family as part of[...]
